| 000 | 01863 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517191400.0 | ||
| 264 | 0 | _c20180918 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1477-0903 | ||
| 024 | 7 |
_a10.1177/0960327117692133 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPaudel, Y N | |
| 245 | 0 | 0 |
_aEvaluation of 4-methyl-2-[(2-methylbenzyl) amino]-1,3-thiazole-5-carboxylic acid against hyperglycemia, insulin sensitivity, and oxidative stress-induced inflammatory responses and β-cell damage in the pancreas of streptozotocin-induced diabetic rats. _h[electronic resource] |
| 260 |
_bHuman & experimental toxicology _cFeb 2018 |
||
| 300 |
_a163-174 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBiomarkers _xblood |
| 650 | 0 | 4 |
_aBlood Glucose _xdrug effects |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xblood |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xblood |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aGlycated Hemoglobin _xmetabolism |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 |
_aInflammation Mediators _xblood |
| 650 | 0 | 4 |
_aInsulin _xblood |
| 650 | 0 | 4 | _aInsulin Resistance |
| 650 | 0 | 4 |
_aInsulin-Secreting Cells _xdrug effects |
| 650 | 0 | 4 |
_aInterleukin-6 _xblood |
| 650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 | _aStreptozocin |
| 650 | 0 | 4 |
_aThiazoles _xpharmacology |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
| 700 | 1 | _aAli, M R | |
| 700 | 1 | _aBawa, S | |
| 700 | 1 | _aShah, S | |
| 700 | 1 | _aAdil, M | |
| 700 | 1 | _aSiddiqui, A | |
| 700 | 1 | _aBasheer, A S | |
| 700 | 1 | _aHassan, M Q | |
| 700 | 1 | _aSharma, M | |
| 773 | 0 |
_tHuman & experimental toxicology _gvol. 37 _gno. 2 _gp. 163-174 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1177/0960327117692133 _zAvailable from publisher's website |
| 999 |
_c27881585 _d27881585 |
||